Riskpilot← Back to searchSign inGet full accessNORWEGIANFYSIO AS
ASActiveOrg 927069962Espens Vei 14, 1391 VollenPhysiotherapy activities · NACE 8695Est. 20211 employees
Revenue 2024
NOK 1,1M
-41% vs 2023
EBITDA margin
-6.8%
-113% vs 2023
Equity ratio
96.3%
Financial strength
Net profit 2024
NOK -8K
-102% vs 2023
| Revenue | NOK 1,1M | -41% |
| EBITDA | NOK -74K | -113% |
| Net profit | NOK -8K | -102% |
| Total assets | NOK 876K | -21% |
| Equity | NOK 844K | -1% |
| Employees | 1 | — |
Legal name
NORWEGIANFYSIO AS
Org number
927069962
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
5. mai 2021
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap. Daglig leder alene.
Company purpose
Fysioterapi, behandling, trening og udnervisning.
Address
Espens Vei 14, 1391 Vollen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 1 186 | 1 350 | 1 844 | 1 087 |
| Staff expenses | −600 | −982 | −785 | −601 |
| EBITDA | 544 | 19 | 578 | −74 |
| Depreciation & amort. | −0 | −23 | −68 | −0 |
| EBIT | 544 | −4 | 510 | −74 |
| Net financials | 0 | 0 | 1 | −0 |
| Profit before tax | 544 | −4 | 511 | −74 |
| Tax | 119 | −0 | 111 | −66 |
| Net profit | 426 | −4 | 400 | −8 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 695 | 625 | 1 109 | 876 |
| Equity | 456 | 452 | 852 | 844 |
| Long-term debt | 0 | 0 | 0 | −66 |
| Short-term debt | 239 | 172 | 257 | 98 |
| Total debt | 239 | 172 | 257 | 32 |
EBITDA margin
-6.8%
This company
15.8%
Market median
-143% vs market
20212024
Equity ratio
96.3%
This company
38.2%
Market median
+152% vs market
20212024
Return on equity
-1.0%
This company
18.4%
Market median
-105% vs market
20212024
Net profit margin
-0.8%
This company
8.1%
Market median
-110% vs market
20212024
Asset turnover
1.24×
This company
1.12×
Market median
+11% vs market
20212024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-03-17 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HJ Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
HP Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NORWEGIANFYSIO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Pay | Chief Executive Officer | 0 companies |
| Henrik Jin Pay | Chief Executive Officer | 0 companies |
| Frederik Horn | Board of Directors | 0 companies |
| Kristian Krane Eriksen | Board of Directors | 0 companies |